HYPERTONIC NASAL CARE
Hypertonic saline with dexpanthenol
Hypertonic saline with dexpanthenol in a nasal spray format.
Complete selected ingredient declaration
Peppermint oil; eucalyptus oil; dexpanthenol; sodium chloride; propylene glycol; poloxamer407; sodium benzoate; potassium dihydrogen phosphate; dipotassium hydrogen phosphate; potassium sorbate; water.
Published component amounts
The source publishes the constituent list but no numerical functional-ingredient concentrations. No concentration has been inferred.
Each row retains its source basis. Amounts per tablet, daily portion, 100 g, 100 mL and prepared serving are distinct. “Not published” means undisclosed, not zero. Raw-material input masses and processing allowances require the manufacturer specification.
Development status
This specialist format is a formulation development profile. Source medicine, medical-device or cosmetic status and approvals do not transfer to PHARMED. The responsible manufacturer must establish the final intended use, classification, directions, safety and market label.
The shared label design
This is the exact front artwork used in the catalogue and measured factory artwork. The three-dimensional packaging image illustrates its presentation.
Open the master front